However, 15 of the 65 patients (23%) developed hypoglycemia, and their antidiabetic therapy were as follows: SU + MET + DPP4-I + SGLT2-I in 4 patients, SU + DPP4-I + SGLT2-I in 2 patients, SU + MET + SGLT2-I in 1 patient, SU + αGI + DPP4-I + SGLT2-I in 1 patient, MET + DPP4-I in 1 patient, MET + insulin in 1 patient, MET + DPP4-I + SGLT2-I in 1 patient, MET + αGI + DPP4-I in 1 patient, pioglitazone + insulin in 1 patient, MET alone in 1 patient, and SGLT2-I alone in 1 patient. Here, INS is linked to Hypoglycemia.